Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Menadione sodium bisulfite is a **synthetic, water-soluble derivative of vitamin K** (specifically, vitamin K3) used primarily for **treatment and prevention of vitamin K deficiency**, particularly where oral intake of vitamin K1 or K2 is not feasible or is ineffective. It acts as a **vitamin K precursor**, aiding in the hepatic synthesis of active clotting factors (II, VII, IX, X) and anticoagulant proteins, and is used both in **human and veterinary medicine** for the prevention of bleeding disorders. Its mechanisms include the restoration of vitamin K-dependent carboxylation needed for functional coagulation proteins. It is also used in dietary supplements, food fortification, and animal feed, as well as in research settings for studying vitamin K biochemistry, and occasionally in cosmetics for its antioxidant and cell-reparative properties.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on menadione sodium bisulfite.